News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
Registration Now Open for RECOVER-TLC Kick-off Meeting, September 23-25, 2024
Working together during this three-day event, scientists, doctors, government officials, and people affected by Long COVID will help shape the future of RECOVER clinical trials.
Announcement
Routine lab tests are not a reliable way to diagnose Long COVID
Findings from this RECOVER study will inform future efforts to develop tools for diagnosing Long COVID.
News Release
Study suggests reinfections from the virus that causes COVID-19 likely have similar severity as original
NIH-funded analysis of health record data shows severe reinfections often follow severe first infections.
Announcement
Expert committee proposes a new working definition of Long COVID
The National Academies of Sciences, Engineering, and Medicine (NASEM) recommends that researchers, healthcare professionals, and government agencies adopt its new working definition of Long COVID to help ease the suffering of millions of people.
Announcement
RECOVER expands its data collection efforts through the Digital Health Program
Information collected in real time will help researchers learn more about the daily lives of people affected by Long COVID.
Feature
R3 Seminar Recap: RECOVER-SLEEP and RECOVER-ENERGIZE – Clinical Trials for Sleep Disturbances, Exercise Intolerance, and Post Exertional Malaise Due to Long COVID
During the June 25th RECOVER Research Review (R3) Seminar, researchers presented details about RECOVER-SLEEP, which included two trials focused on identifying potential treatments for sleep disturbances. Researchers also shared details about RECOVER-ENERGIZE, which included one trial focused on potential treatments for exercise intolerance and one trial examining potential treatments for post-exertional malaise. All the trials were recruiting adults experiencing one or more of these symptoms after having COVID. The presentation also included updates on other RECOVER clinical trials in progress.
R3 Seminar Recap
RECOVER researchers publish pediatric study design
The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Announcement
R3 Seminar Recap: SARS-CoV-2 infection during pregnancy and development of Long COVID
During the May 14th RECOVER Research Review (R3) Seminar, researchers presented findings from the RECOVER pregnancy observational cohort and EHR cohort about the association of SARS-CoV-2 infection during pregnancy and development of Long COVID.
R3 Seminar Recap